Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Cardiol Therapeutics Inc CRDL


Primary Symbol: T.CRDL Alternate Symbol(s):  T.CRDL.W.A

Healthcare
Cardiol Therapeutics Inc. (Cardiol) is a Canada-based clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). The Company's lead product, CardiolRx, is a pharmaceutically produced oral cannabidiol formulation that is in a Phase II/III study in hospitalized patients testing positive... see more

TSX:CRDL - Post Discussion

Cardiol Therapeutics Inc > Orphan Drug Designation Sends Shares of this Dual-Listed Lif
View:
Post by whytestocks on Feb 15, 2024 2:45pm

Orphan Drug Designation Sends Shares of this Dual-Listed Lif

BREAKING NEWS: $CRDL Orphan Drug Designation Sends Shares of this Dual-Listed Life Science Therapy Company Soaring2024-02-15 14:25:53 ET %OrphanDrug designation, or ODD, is valuable on both a humanitarian and a profitability basis. And this company is seeing shares rally following news that it was granted the designation for the treatment of %Pericarditis , the swelling, and irritation of the t...CRDL - Orphan Drug Designation Sends Shares of this Dual-Listed Life Science Therapy Company Soaring
Be the first to comment on this post
Cardiol Therapeutics Inc